(Abst.) Comparative effectiveness of ofatumumab and ocrelizumab in relapsing MS... on: August 15, 2026, 03:59:08 pm #1 From PubMed (August 15, 2026)--"Comparative effectiveness of ofatumumab and ocrelizumab in relapsing MS: A target trial emulation using multinational registry data": pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
